Magazine Article | September 1, 2020

Drug Pricing Reform Twists And Turns In The COVID-19 Era

Source: Life Science Leader

By Frank Zhou, Sonia Khurana, & Julia Gaebler, Ph.D.

In late 2019, there was strong political momentum toward drug pricing reform, with an expectation of legislation in the first few months of 2020. In an uncommon display of bipartisanship, both the House and the Senate had drafted or passed relevant legislation with significant common ground.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: